Published in Nat Clin Pract Cardiovasc Med on March 01, 2009
Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application. J Cell Mol Med (2010) 1.00
Development of bioartificial myocardium using stem cells and nanobiotechnology templates. Cardiol Res Pract (2010) 0.90
Hyaluronic acid-human blood hydrogels for stem cell transplantation. Biomaterials (2012) 0.85
Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review. J R Soc Interface (2015) 0.82
Nano-regenerative medicine towards clinical outcome of stem cell and tissue engineering in humans. J Cell Mol Med (2012) 0.81
Tuning cell adhesion on titanium with osteogenic rosette nanotubes. J Biomed Mater Res A (2010) 0.80
Development of bioartificial myocardium by electrostimulation of 3D collagen scaffolds seeded with stem cells. Heart Int (2012) 0.78
The synthesis and coupling of photoreactive collagen-based peptides to restore integrin reactivity to an inert substrate, chemically-crosslinked collagen. Biomaterials (2016) 0.78
Multilayered Magnetic Gelatin Membrane Scaffolds. ACS Appl Mater Interfaces (2015) 0.75
Hyaluronic acid-serum hydrogels rapidly restore metabolism of encapsulated stem cells and promote engraftment. Biomaterials (2015) 0.75
Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell Biol (2006) 11.29
Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol (2006) 8.81
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med (2006) 4.74
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med (2007) 3.98
Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett (1985) 3.50
Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med (2008) 2.68
Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol (2006) 2.48
Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol (2003) 2.42
Integrins and the myocardium. Circ Res (2001) 2.12
Costameres, focal adhesions, and cardiomyocyte mechanotransduction. Am J Physiol Heart Circ Physiol (2005) 2.05
Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol (2001) 1.90
Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J (2000) 1.74
Role of oxidative stress in cardiac dysfunction of PPARalpha-/- mice. Am J Physiol Heart Circ Physiol (2007) 1.73
Cardiac tissue engineering using perfusion bioreactor systems. Nat Protoc (2008) 1.65
Myocardial cell therapy at the crossroads. Nat Clin Pract Cardiovasc Med (2007) 1.54
Myofibrillar architecture in engineered cardiac myocytes. Circ Res (2008) 1.48
Integrin signalling: the tug-of-war in heart hypertrophy. Cardiovasc Res (2006) 1.45
Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation (2002) 1.45
Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev (2007) 1.44
Cardiac grafting of engineered heart tissue in syngenic rats. Circulation (2002) 1.43
Myocardial tissue engineering: the extracellular matrix. Eur J Cardiothorac Surg (2008) 1.43
Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat Clin Pract Cardiovasc Med (2006) 1.41
Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng (2002) 1.32
Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood (1992) 1.28
Cardiac tissue engineering for replacement therapy. Heart Fail Rev (2003) 1.09
Integrin activation in the heart: a link between electrical and contractile dysfunction? Circ Res (2006) 0.98
Current state of the art in myocardial tissue engineering. Tissue Eng (2007) 0.94
The future of regenerative therapy in patients with chronic heart failure. Nat Clin Pract Cardiovasc Med (2006) 0.92
Concept and progress in the development of RGD-containing peptide pharmaceuticals. Biopolymers (1995) 0.90
The beta integrins and cytoskeletal nanoimprinting. Exp Cell Res (2007) 0.88
Modification of the adhesive properties of collagen by covalent grafting with RGD peptides. J Biomater Sci Polym Ed (2000) 0.87
Numerical density of cardiomyocytes in chronic nitric oxide synthesis inhibition. Pathobiology (2000) 0.86
Real-time kinetics of sarcomere relaxation by laser diffraction. Circ Res (1985) 0.86
Embryonic stem cells: from bench to bedside. Clin Pharmacol Ther (2007) 0.84
Mechanics, energetics, and crossbridge kinetics of rabbit diaphragm during congestive heart failure. FASEB J (1998) 0.84
The future of cell therapy for acute myocardial infarction. Nat Clin Pract Cardiovasc Med (2006) 0.84
Gene therapy and stem cell therapy for cardiovascular diseases today: a model for translational research. Nat Clin Pract Cardiovasc Med (2007) 0.82
Stretching to meet needs: integrin-linked kinase and the cardiac pump. Genes Dev (2006) 0.81
Integrins: regulators of embryogenesis. Biol Cell (2000) 0.81
Cell therapy for cardiac disease: where do we go from here? Nat Clin Pract Cardiovasc Med (2007) 0.79
Retracted Clinically established hemostatic scaffold (tissue fleece) as biomatrix in tissue- and organ-engineering research. Tissue Eng (2003) 0.79
Stem-cell research: after the gold rush. Nature (2005) 0.79
Cardiac valve surgery--the "French correction". J Thorac Cardiovasc Surg (1983) 5.82
Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med (2000) 5.53
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Revival of the radial artery for coronary artery bypass grafting. Ann Thorac Surg (1992) 3.69
Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med (1991) 3.69
Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res (2003) 3.22
Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg (1980) 2.97
Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med (1994) 2.93
Femtosecond photolysis of CO-ligated protoheme and hemoproteins: appearance of deoxy species with a 350-fsec time constant. Proc Natl Acad Sci U S A (1983) 2.91
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology (2007) 2.52
Endoscopic coronary artery bypass grafting with the aid of robotic assisted instruments. J Thorac Cardiovasc Surg (1999) 2.46
Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature (2000) 2.41
AMPA receptor subunits expressed by single Purkinje cells. Neuron (1992) 2.41
Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol (2000) 2.40
A new reconstructive operation for correction of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg (1971) 2.32
Clinical use of respiratory changes in arterial pulse pressure to monitor the hemodynamic effects of PEEP. Am J Respir Crit Care Med (1999) 2.28
Cardiac valve papillary fibroelastoma: surgical excision for revealed or potential embolization. J Thorac Cardiovasc Surg (1999) 2.24
Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation (2001) 2.20
Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg (2001) 2.16
A new formula for estimating mean aortic pressure. Lancet (1999) 2.14
Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans. Am J Physiol (1998) 2.09
Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg (1969) 2.04
Decreased regional blood flow in patients with acromegaly. Clin Endocrinol (Oxf) (1998) 1.99
The surgical treatment of constrictive fibrous endocarditis. Ann Surg (1976) 1.81
Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations. Biotechniques (2002) 1.80
Myosin isoenzymic distribution correlates with speed of myocardial contraction. J Mol Cell Cardiol (1981) 1.79
Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry (2008) 1.78
The aorta-to-coronary radial artery bypass graft. A technique avoiding pathological changes in grafts. Ann Thorac Surg (1973) 1.71
Discovery and validation of blood biomarkers for suicidality. Mol Psychiatry (2013) 1.69
Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry (2009) 1.68
Pulmonary artery pulse pressure and wave reflection in chronic pulmonary thromboembolism and primary pulmonary hypertension. J Am Coll Cardiol (2001) 1.65
High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr (1993) 1.64
Homograft replacement of the mitral valve. Graft selection, technique of implantation, and results in forty-three patients. J Thorac Cardiovasc Surg (1996) 1.60
Cardiac pheochromocytomas. Ann Thorac Surg (1992) 1.55
Haemodynamic evaluation of pulmonary hypertension. Eur Respir J (2002) 1.53
Arrhythmogenic right ventricular dysplasia. Annu Rev Med (1999) 1.52
Left ventricular outflow tract obstruction after mitral valve repair. Results of the sliding leaflet technique. Circulation (1993) 1.52
The radial artery for coronary artery bypass grafting: clinical and angiographic results at five years. J Thorac Cardiovasc Surg (1998) 1.49
Valve repair with Carpentier techniques. The second decade. J Thorac Cardiovasc Surg (1990) 1.49
Comparison of the acute hemodynamic effects of hypertonic or colloid infusions immediately after mitral valve repair. Crit Care Med (1999) 1.48
Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophy. Clin Nutr (2009) 1.45
Peripheral vascular involvement in heart transplant patients. Ann Vasc Surg (1994) 1.43
Angiographic and electron-beam computed tomography studies of retrograde cardioplegia via the coronary sinus. J Thorac Cardiovasc Surg (1996) 1.43
Congenital malformations of the mitral valve in children. Pathology and surgical treatment. J Thorac Cardiovasc Surg (1976) 1.42
Origin of cells in the coronary intima during acute vascular rejection of the transplanted human heart. J Heart Lung Transplant (1992) 1.41
Sarcomere relaxation in hamster diaphragm muscle. J Appl Physiol (1985) (1996) 1.40
[Ascending aortic ectasia. New reinforcement technique]. Presse Med (1991) 1.39
[Chronic meningitis before diagnosis of celiac disease]. Rev Neurol (Paris) (2002) 1.39
Cell adhesion and migration are regulated at distinct stages of thymic T cell development: the roles of fibronectin, VLA4, and VLA5. J Exp Med (1996) 1.39
Early extubation after mitral valve surgery: a target-controlled infusion of propofol and low-dose sufentanil. J Cardiothorac Vasc Anesth (1997) 1.38
Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients. J Am Coll Cardiol (1990) 1.38
Correspondence between functional magnetic resonance imaging somatotopy and individual brain anatomy of the central region: comparison with intraoperative stimulation in patients with brain tumors. J Neurosurg (2000) 1.35
Six-year follow-up of glutaraldehyde-preserved heterografts. With particular reference to the treatment of congenital valve malformations. J Thorac Cardiovasc Surg (1974) 1.35
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest (1999) 1.35
Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation (2001) 1.34
Initial chemotherapy in gliomatosis cerebri. Neurology (2004) 1.33
Surgical treatment of constrictive fibrous endocarditis. J Thorac Cardiovasc Surg (1981) 1.32
Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A (2001) 1.32
Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med (1997) 1.31
CD81 expressed on human thymocytes mediates integrin activation and interleukin 2-dependent proliferation. J Exp Med (1996) 1.29
Combined coronary and femoral revascularization using an ascending aorta to bifemoral bypass. Arch Surg (1994) 1.28
Left ventricular outflow obstruction after mitral valve repair (Carpentier's technique). Proposed mechanisms of disease. Circulation (1988) 1.27
Conservative management of the prolapsed mitral valve. Ann Thorac Surg (1978) 1.27
Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem (1995) 1.27
[Fibrous endocarditis of the left ventricle in a patient with filariasis; surgical cure]. Arch Mal Coeur Vaiss (1973) 1.25
Xenotransplantation and xenogeneic infections. N Engl J Med (1995) 1.25
[Open heart operation under videosurgery and minithoracotomy. First case (mitral valvuloplasty) operated with success]. C R Acad Sci III (1996) 1.22
Comparison of three molecular typing methods in studies of transmission of Porphyromonas gingivalis. J Med Microbiol (1993) 1.21
Expression and function of alpha(v)beta(3) and alpha(v)beta(5) integrins in the developing pancreas: roles in the adhesion and migration of putative endocrine progenitor cells. J Cell Biol (2000) 1.20
Update on counterfeit antibiotics worldwide; public health risks. Med Mal Infect (2012) 1.20
Management of hydrocephalus in pediatric patients with posterior fossa tumors: the role of endoscopic third ventriculostomy. J Neurosurg (2001) 1.18
Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipients. Ann Surg (2000) 1.14
Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology (2004) 1.14
Cytoskeleton and mitochondrial morphology and function. Mol Cell Biochem (1998) 1.14
Double mitral homograft for recurrent bacterial endocarditis of the mitral and tricuspid valves. J Heart Valve Dis (1994) 1.13
Computer-assisted cardiac surgery. Lancet (1999) 1.13
The metabolic syndrome. Pathol Biol (Paris) (2006) 1.12
Valve extension with glutaraldehyde-preserved autologous pericardium. Results in mitral valve repair. J Thorac Cardiovasc Surg (1991) 1.12
Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia (2006) 1.12
Myocardial substitution with a stimulated skeletal muscle: first successful clinical case. Lancet (1985) 1.11
Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc Pathol (2000) 1.10
Implication of HLA-G molecule in heart-graft acceptance. Lancet (2000) 1.09
Continuing improvements in valvular bioprostheses. J Thorac Cardiovasc Surg (1982) 1.09
Abdominal aortic aneurysmectomy in renal transplant patients. Tex Heart Inst J (1990) 1.08
Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet (1999) 1.07
Spectral evidence for sub-picosecond iron displacement after ligand detachment from hemoproteins by femtosecond light pulses. EMBO J (1983) 1.07
Alpha 3 beta 1 and alpha 6 beta 1 integrins mediate laminin/merosin binding and function as costimulatory molecules for human thymocyte proliferation. J Immunol (1995) 1.07
Valve repair in acute endocarditis. Ann Thorac Surg (1990) 1.06
[Implantation of heterogenic valves in the treatment of aortic cardiopathies]. C R Acad Sci Hebd Seances Acad Sci D (1965) 1.06